Vident Advisory, LLC Glaukos Corp Transaction History

Vident Advisory, LLC

  • $3.62 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$76.4 - $96.33 $166,704 - $210,192
2,182 New
2,182 $206 Million
Q3 2023

Feb 21, 2024
BUY
$69.23 - $79.09 $205,613 - $234,897
2,970 New
2,970 $223 Million
Q3 2023

Nov 14, 2023
BUY
$69.23 - $79.09 $205,613 - $234,897
2,970 New
2,970 $223 Million

Others Institutions Holding GKOS

# of Institutions
303
Shares Held
47M
Call Options Held
75.3K
Put Options Held
157K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.23B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email